IP Library Patent Application 14234901
Patent Application
App. No. 14/234,901

ANITMICROBIAL PEPTIDE PRODUCED BY INTESTINAL LACTOBACILLUS SALIVARIUS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/234,901
Abstract

An antimicrobial peptide having potent antibacterial activity against Listeria monocytogenes and Staphylococcus aureus is described. Also described is an isolated Lactobacillus salivarius DPC6502 strain as deposited with the National Collection of Industrial and Marine Bacteria under the Accession No. NCIMB 41840, and variants thereof, wherein the isolated bacteria and variants thereof express an antimicrobial peptide of the invention.

Claims (15)

1 .- 30 . (canceled)

31 . An isolated bactofensin LSI peptide, comprising the sequence of SEQ ID NO: 2 and not comprising a disulfide bond.

32 . A recombinant vector comprising a nucleic acid sequence encoding the isolated bactofensin LSI peptide of claim 31 .

33 . The recombinant vector of claim 32 , the nucleic acid sequence comprising the sequence of SEQ ID NO: 1.

34 . A host cell comprising the recombinant vector of claim 32 .

35 . A recombinant vector comprising a nucleic acid sequence encoding a bactofension immunity protein having the sequence of SEQ ID NO: 8.

36 . A host cell comprising a recombinant vector of claim 35 .

37 . A pharmaceutical composition comprising:

a bactofensin LSI peptide comprising the sequence of SEQ ID NO: 2 or a cell comprising a nucleic acid encoding a bactofensin LSI peptide comprising the sequence of SEQ ID NO: 2;

in combination with a suitable pharmaceutical excipient.

38 . An isolated Lactobacillus salivarius DPC6502 strain as deposited with the National Collection of Industrial and Marine Bacteria under the Accession No. NCIMB 41840 on 9 May 2011, wherein the isolated bacteria expresses an antimicrobial peptide of SEQ ID NO: 2 (designated Bactofensin LS1), or a variant thereof having at least 90% sequence identity to SEQ ID NO: 2, and wherein the antimicrobial peptide of SEQ ID NO: 2, or the variant thereof, have potent antibacterial activity against Listeria monocytogenes and Staphylococcus aureus.

39 . A method of inhibiting the growth of Listeria or Staphylococcus , the method comprising contacting the Listeria or Staphylococcus with an agent selected from the group consisting of:

a bactofensin LSI peptide comprising the sequence of SEQ ID NO: 2;

a recombinant vector comprising a nucleic acid encoding a bactofensin LSI peptide comprising the sequence of SEQ ID NO: 2; or

a host cell comprising a recombinant vector comprising a nucleic acid encoding a bactofensin LSI peptide comprising the sequence of SEQ ID NO: 2.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2014
From: ROSS, PAUL
To: TEAGASC FOOD RESEARCH CENTRE
Reel/Frame 033068/0725 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2014
From: O'SHEA, EILEEN F.; HILL, COLIN
To: UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK
Reel/Frame 033123/0741 →